Sarcopenia as a Predictor of Mortality and Complications in Cirrhosis Patients-A Prospective Cohort Study

<i>Background: </i>Sarcopenia has emerged as an important prognostic factor in cirrhosis patients. A standardized definition of sarcopenia was not used in many of the studies. EWGSOP2 2019 guidelines define sarcopenia in an objective manner. Ultrasound-guided measurement of thigh muscle thickness is a validated and cost effective tool for the assessment of muscle quantity. Aim of the study was to evaluate the predictive role of sarcopenia on mortality and complications in cirrhosis patients.<i> Methods: </i>It was a prospective cohort study with 143 consecutive patients each in sarcopenia and no sarcopenia groups. Sarcopenia was diagnosed as per EWGSOP2 guidelines incorporating ultrasound-guided thigh muscle thickness measurement. They were studied at 6 months for development of complications and mortality. Kaplan-Meier analysis was used to compare survival and Cox proportional hazards model was used to determine risk factors of mortality.<i> Results: </i>Cirrhosis patients with sarcopenia [M:F=97:46] and without sarcopenia [M:F=111:32] were followed up for 6 months. Survival analysis showed a six-month cumulative survival of 58.0% (95%CI 57.92-58.08) and 76.2% (95% CI 76.13-76.27) in sarcopenia and no sarcopenia groups respectively (p-value 0.001). Six-month cumulative survival in patients with severe sarcopenia was 23.8% and in non-severe sarcopenia was 70.1% (p-value 0.001). Multivariate analysis showed sarcopenia (HR=1.498,95%CI 1.081-2.148), female sex (HR=1.86,95%CI 1.102-3.089), Child Pugh class C (HR=1.458,95%CI 1.214-1.775) and MELD-Na score>15 (HR=1.122,95%CI 1.068-2.212) as independent predictors of mortality. Complications like ascites, HE, Covid 19 infection and UGI bleed were significantly higher in the sarcopenia group.<i> Conclusion: </i>Sarcopenia is an independent prognostic marker of mortality in cirrhosis patients and is associated with an increased risk of complications. Severe sarcopenia has even poorer outcome.

Authors

Institutions

Publication Details

Journal
International Journal of Gastroenterology
Published
2024-12-30
DOI
https://doi.org/10.11648/j.ijg.20240802.15
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sarcopenia as a Predictor of Mortality and Complications in Cirrhosis Patients-A Prospective Cohort Study

Sunil Kandiyil, Sandesh Kolassery, Kadavanoor Srijith, Nidhin Devadas et al.
International Journal of Gastroenterology
Nutrition and Health in Aging
article

Sarcopenia as a Predictor of Mortality and Complications in Cirrhosis Patients-A Prospective Cohort Study

Sunil Kandiyil, Sandesh Kolassery, Kadavanoor Srijith, Nidhin Devadas, Sithara Balagopal
article en

Abstract

<i>Background: </i>Sarcopenia has emerged as an important prognostic factor in cirrhosis patients. A standardized definition of sarcopenia was not used in many of the studies. EWGSOP2 2019 guidelines define sarcopenia in an objective manner. Ultrasound-guided measurement of thigh muscle thickness is a validated and cost effective tool for the assessment of muscle quantity. Aim of the study was to evaluate the predictive role of sarcopenia on mortality and complications in cirrhosis patients.<i> Methods: </i>It was a prospective cohort study with 143 consecutive patients each in sarcopenia and no sarcopenia groups. Sarcopenia was diagnosed as per EWGSOP2 guidelines incorporating ultrasound-guided thigh muscle thickness measurement. They were studied at 6 months for development of complications and mortality. Kaplan-Meier analysis was used to compare survival and Cox proportional hazards model was used to determine risk factors of mortality.<i> Results: </i>Cirrhosis patients with sarcopenia [M:F=97:46] and without sarcopenia [M:F=111:32] were followed up for 6 months. Survival analysis showed a six-month cumulative survival of 58.0% (95%CI 57.92-58.08) and 76.2% (95% CI 76.13-76.27) in sarcopenia and no sarcopenia groups respectively (p-value 0.001). Six-month cumulative survival in patients with severe sarcopenia was 23.8% and in non-severe sarcopenia was 70.1% (p-value 0.001). Multivariate analysis showed sarcopenia (HR=1.498,95%CI 1.081-2.148), female sex (HR=1.86,95%CI 1.102-3.089), Child Pugh class C (HR=1.458,95%CI 1.214-1.775) and MELD-Na score>15 (HR=1.122,95%CI 1.068-2.212) as independent predictors of mortality. Complications like ascites, HE, Covid 19 infection and UGI bleed were significantly higher in the sarcopenia group.<i> Conclusion: </i>Sarcopenia is an independent prognostic marker of mortality in cirrhosis patients and is associated with an increased risk of complications. Severe sarcopenia has even poorer outcome.

International Journal of GastroenterologyVol. 8(2)
Government Medical College (IN), Government Medical College (IN), Government Medical College (IN)
Good health and well-being
Openalex Percentile: Top 65%
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.